Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,072) with videos related to
Page
of 108
Sort By:
Nature Communications
|
February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Neuro-Oncology
|
April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients
Javier M Figueroa, Johan Skog, Johnny Akers, et al.
The Journal of Organic Chemistry
|
October 2, 2001
Synthesis of a muscarinic receptor antagonist via a diastereoselective Michael reaction, selective deoxyfluorination and aromatic metal-halogen exchange reaction
T Mase, I N Houpis, A Akao, et al.
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastases
Nora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Erik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Journal of Proteome Research
|
November 5, 2014
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome
Carol L Nilsson, Ekaterina Mostovenko, Cheryl F Lichti, et al.
Page
of 108
Search research articles
Search
Showing results (1011-1020 of 1,072) with videos related to
Sort By:
Page
of 108
Nature Communications
|
February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Nourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Neuro-Oncology
|
April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients
Javier M Figueroa, Johan Skog, Johnny Akers, et al.
The Journal of Organic Chemistry
|
October 2, 2001
Synthesis of a muscarinic receptor antagonist via a diastereoselective Michael reaction, selective deoxyfluorination and aromatic metal-halogen exchange reaction
T Mase, I N Houpis, A Akao, et al.
Neuro-Oncology
|
March 8, 2026
Oncolytic Adenoviral Infection of Chordoma Achieves Treatment Efficacy Associated with Immunologic Response and Tumor Microenvironmental Alteration
Xizi Wu, Daniel Ledbetter, Jen-Wei Tsai, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastases
Nora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2022
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies
Erik H P van Putten, Anne Kleijn, Victor W van Beusechem, et al.
JCI Insight
|
July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration
Martina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial
Shiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.
Journal of Proteome Research
|
November 5, 2014
Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome
Carol L Nilsson, Ekaterina Mostovenko, Cheryl F Lichti, et al.
Page
of 108